Compression Therapy - SA Analysis And Market Forecasts

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.2 Anatomy & Physiology
3.2.1 Chronic Venous Disease
3.2.2 Varicose Veins
3.2.3 Venous Leg Ulcers
3.2.4 Venous Thromboembolism and Deep Vein Thrombosis
3.2.5 Lymphedema
3.3 Clinical Outcomes
3.3.1 Venous Conditions
3.3.2 Lymphedema
3.4 Applications of Technology
3.4.1 Static Compression
3.4.2 Pneumatic Compression Devices
3.5 Advantages and Disadvantages of Technology
3.6 Market Access
3.7 Influence of Clinical Trials
3.8 Regulatory Process
3.8.1 Overview
3.8.2 Brazil
3.9 Reimbursement
3.9.1 Overview
3.9.2 Brazil
3.10 Regulatory Issue & Key Deals
3.10.1 Regulatory Issues & Recalls
3.10.2 Mergers, Acquisitions, and Key Partnerships
3.11 Economic Impact
3.11.1 Indirect Costs
3.11.2 Direct Costs
4 Unmet Needs
4.1 Overview
4.2 Improving Patient Education
4.3 Implementing Consistent Bandaging
4.4 Expanding Caregiver Education
4.5 Enhancing Patient Comfort
4.6 Supporting Patient Mobility
5 Market Opportunity Analysis
5.1 Overview
5.2 Engineering Adjustable Garments for Greater Flexibility
5.3 Developing Multilayer Stockings for Easier Application
5.4 Improving Compression Garments by Adding Sensors
5.5 Innovating Automated Bandaging for Consistent Treatment
6 Market Drivers and Barriers
6.1 Drivers
6.1.1 Aging Populations
6.1.2 Cancer-Related Lymphedema
6.1.3 Rising Rates of Obesity
6.1.4 Lymphatic Filariasis in Underdeveloped Regions
6.1.5 The Need for Cost Savings
6.2 Barriers
6.2.1 Insufficient Reimbursement
6.2.2 Patient Compliance
6.2.3 Cost of Care
6.2.4 Medical Device Excise Tax
6.2.5 Availability of Venture Capital
6.3 Substitutes
6.3.1 Procedures to Prevent Thromboembolism
6.3.2 Invasive and Non-invasive Interventions for Varicose Veins
6.3.3 Surgical Interventions for Lymphedema
6.3.4 Pharmacological Options for DVT Management
7 Competitive Assessment
7.1 Overview
7.2 Technology and Product Offerings
7.3 Product Profile
7.3.1 Covidien (Medtronic)
7.3.2 Sigvaris
7.3.3 BSN Medical
7.3.4 Medi
7.3.5 Laboratoires Innothera
7.3.6 3M Health Care
7.3.7 Thuasne
7.3.8 Paul Hartmann
7.3.9 Mego Afek
7.3.10 Medline Industries
7.3.11 ArjoHuntleigh
7.3.12 DJO Global
7.3.13 Lohmann & Rauscher
7.3.14 Venosan (Salzmann)
7.3.15 Sanyleg
7.3.16 Juzo
7.3.17 Daesung Maref
7.3.18 Bio Compression Systems
7.3.19 Smith & Nephew
7.3.20 Molnlycke Health Care
7.3.21 Gloria Med
7.3.22 B. Braun
7.3.23 Alcare
7.3.24 Derma Sciences
7.3.25 Urgo
7.3.26 Systagenix
7.3.27 Muranaka Medical Instruments
7.3.28 ConvaTec
7.3.29 Xiamen Senyang
7.3.30 Guangzhou Yihao Electronic Technology
7.3.31 Talley Group
7.3.32 Cardinal Health
7.3.33 Tactile Medical
7.3.34 Devon Medical
7.4 SWOT For Each Category of Device
7.4.1 SWOT, Compression Garments
7.4.2 SWOT, Compression Bandages
7.4.3 SWOT, Anti-Embolism Stockings
7.4.4 SWOT, Pneumatic Compression Therapy
8 Pipeline Assessment
8.1 Overview
8.2 Product Profiles
8.2.1 Medical Compression Systems: ActiveCast and ActiveCare Vascular
8.2.2 Epoch Medical Systems: Adaptive Compression for Lower Limb Prosthetics
8.2.3 Footfalls & Heartbeats: Compression Bandage with Textile-based Sensor
9 Clinical Trials to Watch
9.1 Overview
9.2 Clinical Trial Profiles
9.2.1 Evaluation of a Dual Action Pneumatic Compression Device
9.2.2 Treatment Response to Different Lymphedema Compression Programs Using a Pneumatic Compression Device
9.2.3 Two Pneumatic Compression Devices for the Treatment of Lower Extremity Lymphedema
9.2.4 A Hemodynamic Comparison Study of Stationary and Portable Pneumatic Compression Devices
9.2.5 DVT Prevention Study: Geko Neurosmuscular Stimulator vs. Thromboembolism Deterrent Stockings (TEDS)
9.2.6 Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
9.2.7 Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema
9.2.8 Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphedema
10 Current and Future Players
10.1 Overview
10.2 Company Profiles
10.2.1 Covidien (Medtronic)
10.2.2 Sigvaris
10.2.3 BSN Medical
10.2.4 Medi
10.2.5 Innothera
10.2.6 3M Health Care
10.2.7 Thuasne
10.2.8 Paul Hartmann
10.2.9 Mego Afek
10.2.10 Medline Industries
10.2.11 ArjoHuntleigh (Getinge)
10.2.12 DJO Global
10.2.13 Lohmann & Rauscher
10.2.14 Venosan (Salzmann)
10.2.15 Sanyleg (Mimosa)
10.2.16 Juzo
10.2.17 Daesung Maref
10.2.18 Bio Compression Systems
10.2.19 Smith & Nephew
10.2.20 Molnlycke Health Care
10.2.21 Gloria Med
10.2.22 B. Braun
10.2.23 Alcare
10.2.24 Derma Sciences
10.2.25 Laboratoires Urgo
10.2.26 Systagenix (Acelity)
10.2.27 Muranaka Medical Instruments
10.2.28 ConvaTec
10.2.29 Xiamen Senyang
10.2.30 Guangzhou Yihao Electronic Technology
10.2.31 Talley Group
10.2.32 Cardinal Health
10.2.33 Tactile Medical
10.2.34 Devon Medical
10.3 Other Current Players
11 Strategic Competitive Assessment
11.1 Company Market Share
11.1.1 Overview
11.1.2 Company Share in Brazil
12 Market Outlooks by Geography
12.1 Brazil
13 Appendix
13.1 Bibliography
13.2 Abbreviations
13.3 Methodology
13.3.1 Overview
13.3.2 Coverage
13.3.3 Secondary Research
13.4 Forecasting Methodology
13.5 Physicians and Specialists Included in This Study
13.5.1 Key Opinion Leaders
13.5.2 Primary Research Summary
13.6 About the Authors
13.6.1 Shashank Settipalli, Analyst, Medical Devices
13.6.2 Priya Radhakrishnan, MBA, Director, Research and Analysis, Medical Devices
13.7 About GlobalData
13.8 Contact Us
13.9 Disclaimer

1.2 List of Figures
Figure 1: Virchow’s Triad
Figure 2: Brazil Company Market Shares for Static Compression Therapy, 2014
Figure 3: Brazil Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
Figure 4: Brazil Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
Figure 5: Primary Research Participants By Country

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.